STOCK TITAN

[Form 4] DaVita Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Phyllis R. Yale, a director of DaVita Inc. (DVA), reported acquiring 369 shares of DaVita common stock on 08/15/2025 at a reported price of $0. After the reported transaction she beneficially owned 13,570 shares. The Form 4 was filed as an individual filing for one reporting person and was signed by an attorney-in-fact on 08/19/2025.

Phyllis R. Yale, membro del consiglio di DaVita Inc. (DVA), ha comunicato l'acquisto di 369 azioni ordinarie DaVita in data 15/08/2025 a un prezzo segnalato di $0. Dopo l'operazione risultava titolare beneficiaria di 13.570 azioni. Il Form 4 è stato presentato come dichiarazione individuale per una sola persona segnalante ed è stato firmato da un procuratore il 19/08/2025.

Phyllis R. Yale, directora de DaVita Inc. (DVA), informó la adquisición de 369 acciones ordinarias de DaVita el 15/08/2025 a un precio declarado de $0. Tras la operación, poseía beneficiosamente 13.570 acciones. El Formulario 4 (Form 4) se presentó como una declaración individual por una sola persona informante y fue firmado por un apoderado el 19/08/2025.

DaVita Inc.(DVA) 이사회 이사인 Phyllis R. Yale는 2025/08/15에 DaVita 보통주 369주를 보고된 가격 $0에 취득했다고 보고했습니다. 해당 거래 후 그녀는 실질적으로 13,570주를 보유하고 있었습니다. Form 4는 한 명의 신고인에 대한 개인 신고로 제출되었으며 2025/08/19에 위임된 대리인이 서명했습니다.

Phyllis R. Yale, administratrice de DaVita Inc. (DVA), a déclaré l'acquisition de 369 actions ordinaires DaVita le 15/08/2025 à un prix indiqué de 0 $. Après l'opération déclarée, elle détenait effectivement 13 570 actions. Le Formulaire 4 (Form 4) a été déposé en tant que déclaration individuelle pour une seule personne déclarante et a été signé par un mandataire le 19/08/2025.

Phyllis R. Yale, Direktorin von DaVita Inc. (DVA), meldete den Erwerb von 369 DaVita-Stammaktien am 15.08.2025 zu einem angegebenen Preis von $0. Nach der gemeldeten Transaktion hielt sie wirtschaftlich 13.570 Aktien. Das Form 4 wurde als individuelle Meldung für eine meldepflichtige Person eingereicht und am 19.08.2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • Director Phyllis R. Yale reported an acquisition of 369 shares of DaVita common stock on 08/15/2025
  • Beneficial ownership increased to 13,570 shares following the reported transaction
  • Form 4 was filed and signed (via attorney-in-fact), indicating compliance with Section 16 reporting requirements
Negative
  • None.

Insights

TL;DR: A director reported a small, zero-price acquisition of 369 DaVita shares, increasing her beneficial ownership to 13,570 shares.

The filing shows a director-level insider transaction recorded on Form 4 with transaction code "A" indicating acquisition. The reported price of $0 is explicitly stated in the filing; no explanation (e.g., gift, grant, or other) is provided in the document. The size of the transaction is small relative to typical institutional holdings and no derivative transactions or dispositions are reported. The filing was signed by an attorney-in-fact on behalf of the reporting person.

TL;DR: Routine Form 4 disclosure: director acquired 369 shares and now holds 13,570 shares; no derivatives or dispositions disclosed.

The Form 4 is a standard Section 16 filing showing a non-derivative acquisition on 08/15/2025 with no accompanying Table II entries. It confirms compliance with reporting rules by disclosing the transaction and beneficial ownership level. The document contains no additional material facts such as the reason for the $0 price or any change in role or status.

Phyllis R. Yale, membro del consiglio di DaVita Inc. (DVA), ha comunicato l'acquisto di 369 azioni ordinarie DaVita in data 15/08/2025 a un prezzo segnalato di $0. Dopo l'operazione risultava titolare beneficiaria di 13.570 azioni. Il Form 4 è stato presentato come dichiarazione individuale per una sola persona segnalante ed è stato firmato da un procuratore il 19/08/2025.

Phyllis R. Yale, directora de DaVita Inc. (DVA), informó la adquisición de 369 acciones ordinarias de DaVita el 15/08/2025 a un precio declarado de $0. Tras la operación, poseía beneficiosamente 13.570 acciones. El Formulario 4 (Form 4) se presentó como una declaración individual por una sola persona informante y fue firmado por un apoderado el 19/08/2025.

DaVita Inc.(DVA) 이사회 이사인 Phyllis R. Yale는 2025/08/15에 DaVita 보통주 369주를 보고된 가격 $0에 취득했다고 보고했습니다. 해당 거래 후 그녀는 실질적으로 13,570주를 보유하고 있었습니다. Form 4는 한 명의 신고인에 대한 개인 신고로 제출되었으며 2025/08/19에 위임된 대리인이 서명했습니다.

Phyllis R. Yale, administratrice de DaVita Inc. (DVA), a déclaré l'acquisition de 369 actions ordinaires DaVita le 15/08/2025 à un prix indiqué de 0 $. Après l'opération déclarée, elle détenait effectivement 13 570 actions. Le Formulaire 4 (Form 4) a été déposé en tant que déclaration individuelle pour une seule personne déclarante et a été signé par un mandataire le 19/08/2025.

Phyllis R. Yale, Direktorin von DaVita Inc. (DVA), meldete den Erwerb von 369 DaVita-Stammaktien am 15.08.2025 zu einem angegebenen Preis von $0. Nach der gemeldeten Transaktion hielt sie wirtschaftlich 13.570 Aktien. Das Form 4 wurde als individuelle Meldung für eine meldepflichtige Person eingereicht und am 19.08.2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
YALE PHYLLIS R

(Last) (First) (Middle)
C/O DAVITA INC
2000 16TH STREET

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 A 369 A $0 13,570 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Stephanie N. Berberich, Attorney-in-Fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for DaVita (DVA)?

Phyllis R. Yale, a director of DaVita Inc., filed the Form 4 (signed by an attorney-in-fact on 08/19/2025).

What transaction was reported on the DaVita Form 4 (DVA)?

An acquisition of 369 shares of DaVita common stock was reported with transaction date 08/15/2025 and a reported price of $0.

How many DaVita shares does the reporting person beneficially own after the transaction?

13,570 shares beneficially owned following the reported transaction.

Was any derivative security reported on this Form 4 for DVA?

No. Table II for derivative securities contains no entries in this filing.

What does the transaction code on the Form 4 indicate?

Transaction code "A" is shown in the filing, indicating an acquisition; no further explanation is provided in the document.
Davita Inc

NYSE:DVA

DVA Rankings

DVA Latest News

DVA Latest SEC Filings

DVA Stock Data

9.77B
35.76M
49.99%
52.46%
8.24%
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States
DENVER